When Jennie Mixon had gastric bypass surgery in February 2024, she weighed 245 pounds, and was a Type 2 diabetic in Stage 3 liver failure. Today, the 53-year-old is no longer diabetic. She lost half ...

Genius Sports CEO Mark Locke is pushing back after investors rattled the company’s stock over its $1.2 billion deal for digital sports and gaming media network Legend. In a letter to shareholders ...

Dushay is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center. It makes my head spin to think about how much GLP-1s ...

Genius Sports is a picks-and-shovels investment of sorts to the sports betting industry. By adding Legened, the company hopes to better monetize the data from its sports betting capabilities. The deal ...

Genius Sports Limited (NYSE: GENI) on Thursday announced an agreement to acquire Legend in a transaction valued at up to $1.2 billion. The deal includes $900 million payable at closing, $800 million ...

Connor Zilischis the name that everyone is looking forward to in 2026. His antics in the 2025 season made him an instant favorite among the fans. Since then, Zilisch has been a driver who even NASCAR ...

GLP-1 medications — including Ozempic and Wegovy — have soared in popularity over the past few years. But as demand for these weight loss drugs skyrockets, many people are left with questions about ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. January has a funny way of making us ambitious.

Taiwan Semiconductor is a broader way to play the AI buildout trend. Data center capital expenditures are expected to rise through at least 2030. Chip designers have one thing in common: they all turn ...

DOCTOR, WEIGHT LOSS MEDICATION HAS BEEN ALL OVER THE HEADLINES. BUT ARE THEY REALLY YOUR BEST OPTION FOR WEIGHT LOSS? WELL, MERCY MEDICAL CENTER DOCTOR KULDEEP SINGH IS JOINING US LIVE WITH MORE. AND ...

In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," talks with Christle Guevarra, DO, MS, about her struggle with weight, her journey with GLP-1 drugs, and her career in medicine. Following ...